DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $27.00 by Analysts at Evercore ISI

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective reduced by Evercore ISI from $29.00 to $27.00 in a report issued on Tuesday morning, Benzinga reports. They currently have an outperform rating on the medical instruments supplier’s stock.

Several other analysts have also issued reports on the stock. Needham & Company LLC restated a buy rating and issued a $34.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, August 20th. Barrington Research restated an outperform rating and issued a $36.00 price objective on shares of DENTSPLY SIRONA in a report on Friday, September 20th. Stifel Nicolaus dropped their target price on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a hold rating for the company in a report on Thursday, July 18th. Finally, Robert W. Baird cut their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a neutral rating on the stock in a research report on Monday, July 22nd. Five investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of Moderate Buy and a consensus price target of $33.22.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $24.53 on Tuesday. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The company has a 50-day moving average price of $25.26 and a 200 day moving average price of $27.08. DENTSPLY SIRONA has a 12-month low of $23.58 and a 12-month high of $37.60. The stock has a market cap of $5.09 billion, a P/E ratio of -55.75, a PEG ratio of 1.18 and a beta of 1.00.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). The firm had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The firm’s quarterly revenue was down 4.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.51 EPS. Sell-side analysts anticipate that DENTSPLY SIRONA will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.64 annualized dividend and a yield of 2.61%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -145.45%.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. First Eagle Investment Management LLC raised its holdings in DENTSPLY SIRONA by 33.6% in the second quarter. First Eagle Investment Management LLC now owns 13,069,900 shares of the medical instruments supplier’s stock valued at $325,571,000 after acquiring an additional 3,283,965 shares in the last quarter. Wellington Management Group LLP raised its holdings in shares of DENTSPLY SIRONA by 21.1% in the 4th quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after purchasing an additional 1,419,503 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of DENTSPLY SIRONA by 2,959.1% during the 1st quarter. SG Americas Securities LLC now owns 1,373,421 shares of the medical instruments supplier’s stock worth $45,584,000 after purchasing an additional 1,328,525 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of DENTSPLY SIRONA by 42.0% during the second quarter. Dimensional Fund Advisors LP now owns 4,420,445 shares of the medical instruments supplier’s stock worth $110,118,000 after purchasing an additional 1,308,411 shares in the last quarter. Finally, Cooke & Bieler LP increased its holdings in DENTSPLY SIRONA by 16.2% in the second quarter. Cooke & Bieler LP now owns 7,506,845 shares of the medical instruments supplier’s stock valued at $186,996,000 after buying an additional 1,046,105 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.